Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,555 | 196 | 94.8% |
| Travel and Lodging | $148.81 | 2 | 4.0% |
| Grant | $45.00 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $691.82 | 45 | $0 (2024) |
| Medtronic, Inc. | $519.06 | 10 | $0 (2024) |
| Abbott Laboratories | $420.45 | 35 | $0 (2024) |
| Boston Scientific Corporation | $344.33 | 12 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $268.86 | 17 | $0 (2024) |
| PFIZER INC. | $230.90 | 15 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $150.80 | 8 | $0 (2022) |
| Amgen Inc. | $135.32 | 8 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $122.20 | 5 | $0 (2024) |
| CVRx, Inc. | $121.17 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,626 | 68 | Medtronic, Inc. ($519.06) |
| 2023 | $793.80 | 42 | Novartis Pharmaceuticals Corporation ($140.35) |
| 2022 | $435.95 | 26 | Novartis Pharmaceuticals Corporation ($211.82) |
| 2021 | $492.89 | 37 | Abbott Laboratories ($126.31) |
| 2020 | $174.97 | 18 | Abbott Laboratories ($110.17) |
| 2019 | $181.89 | 6 | Boston Scientific Corporation ($116.48) |
| 2018 | $22.56 | 1 | Janssen Pharmaceuticals, Inc ($22.56) |
| 2017 | $20.41 | 1 | Amgen Inc. ($20.41) |
All Payment Transactions
199 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $69.20 | General |
| Category: Cardiovascular Device | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.11 | General |
| Category: Cardiovascular | ||||||
| 12/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.52 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/20/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Not Applicable | ||||||
| 11/08/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $76.25 | General |
| Category: Vascular | ||||||
| 11/05/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $46.46 | General |
| Category: Pacemakers | ||||||
| 11/04/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Vascular | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Genetic Disease | ||||||
| 10/14/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/11/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Heart Failure | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $146.75 | General |
| 10/08/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $76.06 | General |
| 10/08/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $76.06 | General |
| 10/08/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $55.84 | General |
| 10/08/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $39.78 | General |
| Category: Transcatheter Valve Systems | ||||||
| 10/08/2024 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $2.06 | General |
| 10/08/2024 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $0.34 | General |
| 10/03/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.17 | General |
| Category: Cardiovascular | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.39 | General |
| Category: Cardiovascular | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 3,081 | 4,993 | $678,543 | $134,373 |
| 2022 | 26 | 3,138 | 3,868 | $505,371 | $100,834 |
| 2021 | 25 | 3,072 | 3,388 | $508,859 | $109,219 |
| 2020 | 26 | 3,186 | 3,786 | $527,970 | $107,927 |
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 314 | 430 | $111,370 | $27,822 | 25.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Facility | 2023 | 143 | 509 | $98,746 | $17,987 | 18.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Facility | 2023 | 140 | 482 | $80,494 | $10,879 | 13.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 206 | 211 | $53,383 | $9,836 | 18.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 220 | 376 | $39,480 | $7,783 | 19.7% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Facility | 2023 | 133 | 379 | $34,489 | $7,243 | 21.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 116 | 116 | $31,552 | $6,419 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 137 | 147 | $25,872 | $6,214 | 24.0% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 15 | 15 | $25,995 | $5,402 | 20.8% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Facility | 2023 | 82 | 151 | $22,801 | $3,859 | 16.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 586 | 666 | $19,314 | $3,554 | 18.4% |
| 93793 | Anticoagulant management of patient taking warfarin | Facility | 2023 | 40 | 437 | $17,480 | $3,367 | 19.3% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 121 | 126 | $12,096 | $2,278 | 18.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 22 | 22 | $8,602 | $2,015 | 23.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 124 | 124 | $9,548 | $1,933 | 20.2% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Facility | 2023 | 30 | 95 | $8,645 | $1,814 | 21.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 15 | 15 | $5,205 | $1,554 | 29.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 158 | 158 | $8,058 | $1,553 | 19.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 16 | 19 | $7,182 | $1,548 | 21.6% |
| 93280 | Programming of dual lead pacemaker system | Facility | 2023 | 52 | 57 | $7,581 | $1,538 | 20.3% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Facility | 2023 | 45 | 56 | $7,590 | $1,281 | 16.9% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Facility | 2023 | 69 | 88 | $6,512 | $1,161 | 17.8% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 13 | 13 | $5,707 | $1,133 | 19.8% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Facility | 2023 | 30 | 42 | $5,418 | $976.85 | 18.0% |
| 93284 | Programming of multiple lead implantable defibrillator system | Facility | 2023 | 16 | 20 | $4,340 | $932.00 | 21.5% |
About Dr. Benjamin Call, MD
Dr. Benjamin Call, MD is a Cardiovascular Disease healthcare provider based in Pocatello, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346236213.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Call, MD has received a total of $3,749 in payments from pharmaceutical and medical device companies, with $1,626 received in 2024. These payments were reported across 199 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,555).
As a Medicare-enrolled provider, Call has provided services to 12,477 Medicare beneficiaries, totaling 16,035 services with total Medicare billing of $452,353. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Pocatello, ID
- Active Since 09/26/2005
- Last Updated 11/07/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1346236213
Products in Payments
- LEQVIO (Drug) $375.10
- ENTRESTO (Drug) $316.72
- ELIQUIS (Drug) $228.00
- VYNDAQEL (Drug) $174.59
- XARELTO (Drug) $150.80
- Confirm Rx (Device) $136.03
- Repatha (Biological) $123.44
- Barostim Neo System (Device) $121.17
- Arcalyst (Drug) $115.09
- MITRACLIP (Device) $97.49
- AMVUTTRA (Drug) $96.75
- ACCOLADE SR (Device) $81.16
- OPSUMIT (Drug) $78.19
- Assurity Pacemaker (Device) $76.59
- LifeVest (Device) $75.62
- ATTAIN COMMAND + SUREVALVE (Device) $72.39
- CAMZYOS (Drug) $71.64
- SQ RX PULSE GENERATOR (Device) $71.48
- Optimizer (Device) $69.20
- WATCHMAN Access System (Device) $66.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Pocatello
Dr. Mark Richards, M.d, M.D
Cardiovascular Disease — Payments: $374,872
Jacob Delarosa, Md, MD
Cardiovascular Disease — Payments: $169,221
Dr. Fernando Grigera, Md, MD
Cardiovascular Disease — Payments: $5,092
Dr. Jarrah Alfadhli, Md, MD
Cardiovascular Disease — Payments: $1,384
Dr. Chandana Shekar, Md, MD
Cardiovascular Disease — Payments: $325.77
Alfred Narraway, Do, DO
Cardiovascular Disease